Landmark genomic studies such as those from TCGA and the International Cancer Genome Consortium have delineated key hallmarks of CRC, including recurrent mutations in APC, TP53, and KRAS, while underscoring significant inter‐patient variability [31]. The gene discussed is TP53; the disease is colorectal carcinoma.